All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q1 report for ASTRAZENECA on April 18, 2025, reporting $90,000 in lobbying income.

Lobbying for ASTRAZENECA

All filings by TIBER CREEK GROUP · Everything ASTRAZENECA has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$90,000

What the client paid this registrant for the period.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946 - ORPHAN Cures Act.

Bills named in this filing 1

H.R. 946
ORPHAN Cures Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.